Always discuss your supplement routine with your family doctor or pharmacist if you are taking prescription medications.
In a Phase 1 clinical trial, AMG133 demonstrated significant dose-dependent weight loss effects, achieving up to a 14.5% reduction in body weight compared to a 1.5% reduction for the placebo group on day 85
The two assays also showed differing antioxidant activity trends
Clinical Efficacy Specialists : Xian Plantis Biotechnology Co., Ltd
The second transcript (1b) retains the intron and does not function as a receptor for ghrelin
Methylene blue side effects from intravenous treatment are rare and typically under high dosages but include nausea, discoloration of urine, arm or leg pain, change in taste, increased sweating, and feeling hot and cold